학술논문
Efficacy and safety of the glycine transporter type-1 inhibitor AMG 747 for the treatment of negative symptoms associated with schizophrenia
Document Type
Article
Author
Source
In Schizophrenia Research April 2017 182:90-97
Subject
Language
ISSN
0920-9964